Waldron Private Wealth’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$939K Hold
8,810
0.03% 158
2026
Q1
$1.44M Hold
8,810
0.06% 110
2025
Q4
$1.53M Buy
8,810
+10
+0.1% +$1.82K 0.06% 105
2025
Q3
$1.27M Hold
8,800
0.05% 121
2025
Q2
$886K Hold
8,800
0.04% 146
2025
Q1
$671K Hold
8,800
0.03% 161
2024
Q4
$608K Buy
+8,800
New +$634K 0.02% 226

Other funds holding INSM

Waldron Private Wealth's INSM Position: Q2 2026 in Review

Waldron Private Wealth held its Insmed (INSM) position steady in Q2 2026 at 8,810 shares worth $939K. The position accounts for 0.03% of the portfolio, ranked #158.

Waldron Private Wealth first reported a position in INSM in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.53M in Q4 2025. 86 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Waldron Private Wealth held 8,810 shares of Insmed worth $939K as of Q2 2026.
  • Waldron Private Wealth left its Insmed share count unchanged in Q2 2026.
  • Insmed made up 0.03% of Waldron Private Wealth's portfolio in Q2 2026, its #158 holding.
  • Waldron Private Wealth first reported a position in Insmed in Q4 2024 and has held it in 7 quarters since.
  • Waldron Private Wealth's Insmed position peaked at $1.53M in Q4 2025.
  • 86 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Waldron Private Wealth's 13F filing for Q2 2026, filed 20 Jul 2026.